Fred Ramsdell
Fondatore presso Sonoma Biotherapeutics, Inc.
Profilo
Fred Ramsdell is the founder of Sonoma Biotherapeutics, Inc. founded in 2019, where he holds the title of Chief Scientific Officer.
In 2014-2016, he worked as Vice President-Immunology at aTyr Pharma, Inc. Dr. Ramsdell holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California San Diego.
Posizioni attive di Fred Ramsdell
| Società | Posizione | Inizio |
|---|---|---|
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Fondatore | 01/01/2019 |
Precedenti posizioni note di Fred Ramsdell
| Società | Posizione | Fine |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/12/2016 |
Formazione di Fred Ramsdell
| University of California, Los Angeles | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Fred Ramsdell
